title: Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
authors.affiliation: Department of Surgery, University of Chicago, Illinois.
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
authors.forename: J T
authors.initials: JT
authors.lastname: Mayes
authors.forename: J K
authors.initials: JK
authors.lastname: Stuart
authors.forename: T G
authors.initials: TG
authors.lastname: Heffron
authors.forename: B H
authors.initials: BH
authors.lastname: Spargo
authors.forename: F P
authors.initials: FP
authors.lastname: Stuart
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001707:Biopsy, Needle / Q000379:methods*; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone